Lexicon-based sentiment analysis in finance leverages specialized, manually annotated lexicons created by human experts to extract sentiment from financial texts effectively. Although lexicon-based methods are simple to implement and fast to operate on textual data, they require considerable manual annotation efforts to create, maintain, and update the lexicons. These methods are also considered inferior to the deep learning-based approaches, such as transformer models, which have become dominant in various natural language processing (NLP) tasks due to their remarkable performance. However, their efficacy comes at a cost: these models require extensive data and computational resources for both training and testing. Additionally, they involve significant prediction times, making them unsuitable for real-time production environments or systems with limited processing capabilities. In this paper, we introduce a novel methodology named eXplainable Lexicons (XLex) that combines the advantages of both lexicon-based methods and transformer models. We propose an approach that utilizes transformers and SHapley Additive exPlanations (SHAP) for explainability to automatically learn financial lexicons. Our study presents four main contributions. Firstly, we demonstrate that transformer-aided explainable lexicons can enhance the vocabulary coverage of the benchmark Loughran-McDonald (LM) lexicon. This enhancement leads to a significant reduction in the need for human involvement in the process of annotating, maintaining, and updating the lexicons. Secondly, we show that the resulting lexicon outperforms the standard LM lexicon in sentiment analysis of financial datasets. Our experiments show that XLex outperforms LM when applied to general financial texts, resulting in enhanced word coverage and an overall increase in classification accuracy by 0.431. Furthermore, by employing XLex to extend LM, we create a combined dictionary, XLex+LM, which achieves an even higher accuracy improvement of 0.450. Thirdly, we illustrate that the lexicon-based approach is significantly more efficient in terms of model speed and size compared to transformers. Lastly, the proposed XLex approach is inherently more interpretable than transformer models. This interpretability is advantageous as lexicon models rely on predefined rules, unlike transformers, which have complex inner workings. The interpretability of the models allows for better understanding and insights into the results of sentiment analysis, making the XLex approach a valuable tool for financial decision-making.

Drug product data is available on the Web in a distributed fashion. The reasons lie within the regulatory domains, which exist on a national level. As a consequence, the drug data available on the Web are independently curated by national institutions from each country, leaving the data in varying languages, with a varying structure, granularity level and format, on different locations on the Web. Therefore, one of the main challenges in the realm of drug data is the consolidation and integration of large amounts of heterogeneous data into a comprehensive dataspace, for the purpose of developing data-driven applications. In recent years, the adoption of the Linked Data principles has enabled data publishers to provide structured data on the Web and contextually interlink them with other public datasets, effectively de-siloing them. Defining methodological guidelines and specialized tools for generating Linked Data in the drug domain, applicable on a global scale, is a crucial step to achieving the necessary levels of data consolidation and alignment needed for the development of a global dataset of drug product data. This dataset would then enable a myriad of new usage scenarios, which can, for instance, provide insight into the global availability of different drug categories in different parts of the world. We developed a methodology and a set of tools which support the process of generating Linked Data in the drug domain. Using them, we generated the LinkedDrugs dataset by seamlessly transforming, consolidating and publishing high-quality, 5-star Linked Drug Data from twenty-three countries, containing over 248,000 drug products, over 99,000,000 RDF triples and over 278,000 links to generic drugs from the LOD Cloud. Using the linked nature of the dataset, we demonstrate its ability to support advanced usage scenarios in the drug domain. The process of generating the LinkedDrugs dataset demonstrates the applicability of the methodological guidelines and the supporting tools in transforming drug product data from various, independent and distributed sources, into a comprehensive Linked Drug Data dataset. The presented user-centric and analytical usage scenarios over the dataset show the advantages of having a de-siloed, consolidated and comprehensive dataspace of drug data available via the existing infrastructure of the Web.

Food - drug interactions are well studied, however much less is known about cuisine - drug interactions. Non-native cuisines are becoming increasingly more popular as they are available in (almost) all regions in the world. Here we address the problem of how known negative food - drug interactions are spread in different cuisines. We show that different drug categories have different distribution of the negative effects in different parts of the world. The effects certain ingredients have on different drug categories and in different cuisines are also analyzed. This analysis is aimed towards stressing out the importance of cuisine - drug interactions for patients which are being administered drugs with known negative food interactions. A patient being under a treatment with one such drug should be advised not only about the possible negative food - drug interactions, but also about the cuisines that could be avoided from the patient's diet.

GeoSPARQL is an important standard for the geospatial linked data community, given that it defines a vocabulary for representing geospatial data in RDF, defines an extension to SPARQL for processing geospatial data, and provides support for both qualitative and quantitative spatial reasoning. However, what the community is missing is a comprehensive and objective way to measure the extent of GeoSPARQL support in GeoSPARQL-enabled RDF triplestores. To fill this gap, we developed the GeoSPARQL compliance benchmark. We propose a series of tests that check for the compliance of RDF triplestores with the GeoSPARQL standard, in order to test how many of the requirements outlined in the standard a tested system supports. This topic is of concern because the support of GeoSPARQL varies greatly between different triplestore implementations, and the extent of support is of great importance for different users. In order to showcase the benchmark and its applicability, we present a comparison of the benchmark results of several triplestores, providing an insight into their current GeoSPARQL support and the overall GeoSPARQL support in the geospatial linked data domain.

Natural language processing (NLP) is an area of artificial intelligence that applies information technologies to process the human language, understand it to a certain degree, and use it in various applications. This area has rapidly developed in the last few years and now employs modern variants of deep neural networks to extract relevant patterns from large text corpora. The main objective of this work is to survey the recent use of NLP in the field of pharmacology. As our work shows, NLP is a highly relevant information extraction and processing approach for pharmacology. It has been used extensively, from intelligent searches through thousands of medical documents to finding traces of adversarial drug interactions in social media. We split our coverage into five categories to survey modern NLP methodology, commonly addressed tasks, relevant textual data, knowledge bases, and useful programming libraries. We split each of the five categories into appropriate subcategories, describe their main properties and ideas, and summarize them in a tabular form. The resulting survey presents a comprehensive overview of the area, useful to practitioners and interested observers. Significance Statement The main objective of this work is to survey the recent use of NLP in the field of pharmacology, in order to provide a comprehensive overview of the current state in the area after the rapid developments which occurred in the last few years. We believe the resulting survey to be useful to practitioners and interested observers in the domain.

Even though named entity recognition (NER) has seen tremendous development in recent years, some domain-specific use-cases still require tagging of unique entities, which is not well handled by pre-trained models. Solutions based on enhancing pre-trained models or creating new ones are efficient, but creating reliable labeled training for them to learn on is still challenging. In this paper, we introduce PharmKE, a text analysis platform tailored to the pharmaceutical industry that uses deep learning at several stages to perform an in-depth semantic analysis of relevant publications. The proposed methodology is used to produce reliably labeled datasets leveraging cutting-edge transfer learning, which are later used to train models for specific entity labeling tasks. By building models for the well-known text-processing libraries spaCy and AllenNLP, this technique is used to find Pharmaceutical Organizations and Drugs in texts from the pharmaceutical domain. The PharmKE platform also incorporates the NER findings to resolve co-references of entities and examine the semantic linkages in each phrase, creating a foundation for further text analysis tasks, such as fact extraction and question answering. Additionally, the knowledge graph created by DBpedia Spotlight for a specific pharmaceutical text is expanded using the identified entities. The obtained results with the proposed methodology result in about a 96% F1-score on the NER tasks, which is up to 2% better than those of the fine-tuned BERT and BioBERT models developed using the same dataset. The ultimate benefits of the platform are that pharmaceutical domain specialists may more easily identify the knowledge extracted from the input texts thanks to the platform’s visualization of the model findings. Likewise, the proposed techniques can be integrated into mobile and pervasive systems to give patients more relevant and comprehensive information from scanned medication guides. Similarly, it can provide preliminary insights to patients and even medical personnel on whether a drug from a different vendor is compatible with the patient’s prescription medication.